Postmenopausal bleeding a sign of uterine cancer

Postmenopausal bleeding, or menstrual bleeding after more than one year of finishing menopause, can indicate serious medical conditions. One of these conditions is uterine cancer, which according to the Centers for Disease Control and Prevention is the 4th most common cancer among American women.

Apart from bleeding during menopause, other symptoms of uterine cancer include pelvic pain, painful sexual intercourse, and watery vaginal discharge that is sometimes tinged with blood. If you are going through menopause and have experienced bleeding, or even slight spotting, consult with your obstetrician immediately to learn more about your risk of uterine cancer.

You may also be at risk of uterine cancer if you have undergone a laparoscopic procedure involving a power morcellator. If you believe your diagnosis of uterine cancer has resulted from this medical device, a lawyer at Williams Kherkher might be able to guide you through the process of seeking compensation through a lawsuit. Call us at (888) 220-0640 today.


Can hormone replacement therapy increase risk of endometrial cancer?

Endometrial cancer happens when cancerous cells grow and spread in the endometrium, or the inside lining of the uterus. Women who are going through menopause, are obese, or have never been pregnant are all at risk of endometrial cancer. Additionally, women who are undergoing hormone replacement therapy (HRT) to fight against symptoms of menopause are considered more prone to this disease.

One factor that could increase your risk of endometrial cancer is the shift in the balance of two female hormones, progesterone and estrogen. The American Cancer Society stated that taking estrogen without progesterone during HRT increases a woman’s risk of endometrial cancer. As such, it is important to ask your doctor about your endometrial cancer risk before undergoing any type of HRT.

Unfortunately, women who undergo a laparoscopic procedure using a power morcellator are also at risk of endometrial cancer. Consult with our legal team at Williams Kherkher by calling (888) 220-0640 to learn more about taking legal action after being hurt by this dangerous medical device.


Mediterranean diet may decrease endometrial cancer risk – study

Another study adds further backing to the belief that the Mediterranean diet as one of the healthiest around. Researchers have discovered that closely following the Mediterranean diet can reduce the risk of endometrial cancer by up to 57%, Medical News Today reported on May 27.

The study involved 5,000 women picked from different areas in Italy and Switzerland and an analysis of data from 1983 to 2006. The study also divided the Mediterranean diet into nine categories: high intake of vegetables, fruits and nuts, legumes, cereals and potatoes, fish, and monosaturated fats; moderate intake of alcohol; and low intake of meat, and dairy products.

Researchers found that those who strictly adhered with the consumption reduced their risk of endometrial cancer by 57%. On the other hand, those who followed seven and six of the nine categories reduced their risk by 46% and 34%, respectively.

Unfortunately, the risk of endometrial cancer may increase after undergoing a hysterectomy involving a power morcellator. If you think you have been harmed by this medical device in any way, a lawyer at Williams Kherkher might be able to help you file a case against the manufacturer involved. Call us at (888) 220-0640 for a free case assessment today.


FBI investigates Johnson & Johnson over power morcellators

The FBI is currently investigating what, exactly, Johnson & Johnson knew about their laparoscopic power morcellator before it was released and while it was on the market, according to a Wall Street Journal article on May 27.

Power morcellators, often used in hysterectomies, are designed to cut up fibroids in the uterus which are then extracted through small incisions. Unfortunately, however, these devices have resulted in the spread of previously undetected uterine cancer in many women. J & J recalled the product last year but has been receiving alerts about its dangers for at least the past nine years.

A former pathologist contacted the company in 2006 to express his concerns that use of the device would spread cancerous cells, thus further threatening a patient’s health. A J & J spokesperson said that after this communication, an additional warning was added to the instructions, explaining that malignant tissue may be spread through its use.

A physician’s assistant in California accumulated a list of women, including her, whose cancers worsened after the device was used in a medical procedure. The list consists of 386 names. This woman, along with the retired pathologists and others who have spoken out against the power morcellator, has been contacted by the FBI as part of its investigation.

The attorneys of Williams Kherkher are dedicated to representing those whose health has been affected by the use of power morcellators. Call us at (888) 220-0640 today to learn more about holding the responsible parties accountable.


Soft drinks may increase the risk of endometrial cancer

Older age, obesity, early start of menstruation, and hormone therapy are among the many risk factors associated with uterine cancer. But apart from these, a recent study published in the Journal Cancer Epidemiology, Biomarkers & Prevention revealed that soft drinks may also increase your risk of developing this life-threatening disease.

In a study that looked into 23,000 post-menopausal women, individuals who consumed sugar-sweetened drinks were 72% more at risk of uterine cancer. Experts believe sugar-sweetened beverages increase the level of estrogen in the body. Because post-menopausal women are not able to shed their endometrial lining regularly, increased estrogen level may cause their lining to thicken, thereby increasing their risk of uterine cancer.

Unfortunately, these are not the only risk factors associated with endometrial cancer. Power morcellators, for instance, may cause the spread of undetected cancer in the uterus during laparoscopic procedures. To learn more about taking legal action after being harmed by this medical device, consult with our legal team at Williams Kherkher by calling (888) 220-0640 today.


Aetna to curb power morcellator coverage due to cancer risk

Starting on May 15, U.S. health insurer Aetna began limiting its coverage of power morcellator use in hysterectomies over issues that the medical device might spread uterine cancer in women, CBC News reported on May 5.

The third largest health insurer in the country said it is cutting back its coverage for laparoscopic procedures involving power morcellators because their safety has still not been proven. However, the health insurer said it will provide exceptions for pre-menopausal women who want to preserve their fertility and are left with no other effective option. Exceptions will also be provided for women whose lives would be threatened through another treatment.

More and more health insurers in the U.S. are cutting their coverage on procedures involving power morcellator over the device’s risk of spreading undetected uterine cancer. If you have been harmed by this medical device in any way, a lawyer at Williams Kherkher might be able to represent you in a case against the manufacturer involved. Call us at (888) 220-0640 today.


A sedentary lifestyle increases risk of endometrial and breast cancers

A study involving more than 29,000 Swedish women suggested that too much sitting may increase the risk of endometrial and breast cancer, a report by The Huffington Post revealed on April 27.

The study categorized the participants into three groups: those who had a sedentary job and were not active outside of work, those with a sedentary job but were active in sports, and those who both had an active job and an active sports life.

During a follow-up period lasting 25 years, the study found that women in the first group were 2.4 times more likely to develop breast cancer and uterine cancer before menopause than those from the other groups.

Endometrial cancer does not affect only those with an inactive lifestyle. It may also affect those who have undergone laparoscopic uterine surgery involving a power morcellator – a device associated with the spread of undetected cancer in the uterus. To learn more about taking legal action against the maker of this medical device, contact our legal team at Williams Kherkher by calling (888) 220-0640 today.


Brachytherapy treatment improves uterine cancer survival – study

An evaluation of the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database found that women with inoperable early-stage endometrial cancer have a better chance of survival if they undergo treatment that includes brachytherapy (BT) instead of external beam radiotherapy (EBRT) alone, Medscape revealed on April 27.

The study, which involved the analysis of 460 patients’ data from the SEER database, found that patients who took BT or BT with EBRT scored high in both 3-year overall survival and 3-year cause-specific survival. EBRT uses a radiation beam from outside the body to destroy cancer cells. BT, on the other hand, involves placing the source of radiation near the tumor to get rid of the cancer cells.

Women who have undergone a laparoscopic procedure involving power morcellators are at a higher risk of developing uterine cancer. To learn more about taking legal action against the manufacturer after being adversely affected by this medical device, consult with an attorney at Williams Kherkher by calling (888) 220-0640 today.


Health insurers want tighter approval and monitoring of medical devices

In a letter addressed to Sen. Bob Casey on April 14, a large group of health insurers called for tougher approval and monitoring of medical devices, according to a report by The Wall Street Journal.

The demand was in light of a growing number of uterine cancer diagnoses associated with laparoscopic procedures involving power morcellators. Some studies have shown using the medical device may cause undetected cancer tissues to spread in the uterus. The health insurance group America’s Health Insurance Plans said the U.S. Food and Drug Administration (FDA) needs to amend its 510 (k) process–a pre-market process that aims to prove that a medical device is as safe and as effective as a device already approved for the market.

A uterine cancer diagnosis can be frightening and overwhelming. If you believe your health condition has resulted from a power morcellator, the legal team at Williams Kherkher might be able to help you file a claim against the manufacturer involved. Call us at (888) 220-0640 to learn about your legal options today.


Clearing uterine fibroids through cryomyolysis

Uterine fibroids are benign growths in the uterus that might create few to no symptoms, especially when the masses are still small. Some prefer to have their uterine fibroids removed through a laparoscopic procedure involving the use of a power morcellator. Unfortunately, manufacturers of this device have recently been under fire over allegations that power morcellators spread theretofore undetected cancer tissues in the uterus, causing uterine cancer.

Apart from laparoscopic procedures involving a power morcellator, doctors may also recommend cryomyolysis as an option to clear small uterine fibroids. During this procedure, an electrified needle freezes the benign mass. This would then disrupt the flow of blood to the fibroids, cutting off their oxygen supply and nutrition.

If you think a diagnosis of uterine cancer has stemmed from a laparoscopic procedure involving a power morcellator, you might be eligible to file a claim against the maker of the dangerous medical device. The legal team at Williams Kherkher might be able to help. Call us (888) 220-0640 to learn how we may put our experience to work for you.


1 3 4 5 6 7
SEO for Lawyers